• Explore /
  • Poster
  • / Real-world performance of a multi-cancer early detection test based on integrative analysis of cell-free DNA whole-methylome sequencing.

Real-world performance of a multi-cancer early detection test based on integrative analysis of cell-free DNA whole-methylome sequencing.

Abstract Poster

Authors

null

Yulong LI

Genecast Biotechnology Co., Ltd., Beijing, China

Yulong LI , Xiaofeng Song , Ning Shen , Yuanyuan Hong , Ying Yang , Yu S. Huang , Weizhi Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Etiology/Epidemiology

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 10521)

DOI

10.1200/JCO.2023.41.16_suppl.10521

Abstract #

10521

Poster Bd #

154

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Breakthrough

A novel cell-free multi-omics approach for enhancing multi-cancer early detection.

A novel cell-free multi-omics approach for enhancing multi-cancer early detection.

First Author: Thien-Chi Van Van Nguyen

First Author: Li-Yue Sun

First Author: Huiyan Luo

First Author: Li-Yue Sun